Page last updated: 2024-11-05

xylazine and Alloxan Diabetes

xylazine has been researched along with Alloxan Diabetes in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research Excerpts

ExcerptRelevanceReference
"The effects of streptozotocin-induced diabetes and insulin on the duration of xylazine-ketamine anesthesia were studied in rats."7.68Effects of streptozotocin-induced diabetes on xylazine-ketamine anesthesia. ( Amouzadeh, HR; Sangiah, S, 1990)
"The effects of streptozotocin-induced diabetes and insulin on the duration of xylazine-ketamine anesthesia were studied in rats."3.68Effects of streptozotocin-induced diabetes on xylazine-ketamine anesthesia. ( Amouzadeh, HR; Sangiah, S, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amouzadeh, HR1
Sangiah, S1

Other Studies

1 other study available for xylazine and Alloxan Diabetes

ArticleYear
Effects of streptozotocin-induced diabetes on xylazine-ketamine anesthesia.
    Veterinary and human toxicology, 1990, Volume: 32, Issue:1

    Topics: Anesthesia; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Ketamine; Male; Rats;

1990